bupranolol has been researched along with Bradycardia in 1 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eibs, HG | 1 |
| Oberdisse, U | 1 |
| Brambach, U | 1 |
1 other study available for bupranolol and Bradycardia
| Article | Year |
|---|---|
[Intoxication with beta-receptor blockers (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Antidotes; Bradycardia; Bundle-Branch Block; Buprano | 1982 |